135 related articles for article (PubMed ID: 27488420)
1. Comparable Neuroprotective Effects of Pergolide and Pramipexole on Ferrous Sulfate-Induced Dopaminergic Cell Death in Cell Culture.
Reichelt D; Radad K; Moldzio R; Rausch WD; Reichmann H; Gille G
CNS Neurol Disord Drug Targets; 2016; 15(10):1325-1332. PubMed ID: 27488420
[TBL] [Abstract][Full Text] [Related]
2. Cabergoline protects dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture.
Meinel J; Radad K; Rausch WD; Reichmann H; Gille G
Folia Neuropathol; 2015; 53(1):29-40. PubMed ID: 25909873
[TBL] [Abstract][Full Text] [Related]
3. Novel neuroprotective mechanisms of pramipexole, an anti-Parkinson drug, against endogenous dopamine-mediated excitotoxicity.
Izumi Y; Sawada H; Yamamoto N; Kume T; Katsuki H; Shimohama S; Akaike A
Eur J Pharmacol; 2007 Feb; 557(2-3):132-40. PubMed ID: 17161393
[TBL] [Abstract][Full Text] [Related]
4. Pergolide protects dopaminergic neurons in primary culture under stress conditions.
Gille G; Rausch WD; Hung ST; Moldzio R; Janetzky B; Hundemer HP; Kolter T; Reichmann H
J Neural Transm (Vienna); 2002 May; 109(5-6):633-43. PubMed ID: 12111455
[TBL] [Abstract][Full Text] [Related]
5. Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms.
Gu M; Iravani MM; Cooper JM; King D; Jenner P; Schapira AH
J Neurochem; 2004 Dec; 91(5):1075-81. PubMed ID: 15569251
[TBL] [Abstract][Full Text] [Related]
6. Pramipexole has astrocyte-mediated neuroprotective effects against lactacystin toxicity.
Imamura K; Takeshima T; Nakaso K; Ito S; Nakashima K
Neurosci Lett; 2008 Aug; 440(2):97-102. PubMed ID: 18555604
[TBL] [Abstract][Full Text] [Related]
7. Switching from pergolide to pramipexole in patients with Parkinson's disease.
Hanna PA; Ratkos L; Ondo WG; Jankovic J
J Neural Transm (Vienna); 2001; 108(1):63-70. PubMed ID: 11261747
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of levodopa-induced toxicity in mesencephalic cultures by pramipexole.
Carvey PM; Pieri S; Ling ZD
J Neural Transm (Vienna); 1997; 104(2-3):209-28. PubMed ID: 9203083
[TBL] [Abstract][Full Text] [Related]
9. Are dopamine receptor agonists neuroprotective in Parkinson's disease?
Le WD; Jankovic J
Drugs Aging; 2001; 18(6):389-96. PubMed ID: 11419913
[TBL] [Abstract][Full Text] [Related]
10. Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory.
Costa A; Peppe A; Dell'Agnello G; Caltagirone C; Carlesimo GA
Neuropsychologia; 2009 Apr; 47(5):1374-81. PubMed ID: 19428401
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection by pramipexole against dopamine- and levodopa-induced cytotoxicity.
Zou L; Jankovic J; Rowe DB; Xie W; Appel SH; Le W
Life Sci; 1999; 64(15):1275-85. PubMed ID: 10227583
[TBL] [Abstract][Full Text] [Related]
12. Pramipexole protects dopaminergic neurons through paraplegin against 6-hydroxydopamine.
Kim MK; Park HS; Cho JH; Kim GS; Won C
Neuroreport; 2015 Jan; 26(2):74-80. PubMed ID: 25514384
[TBL] [Abstract][Full Text] [Related]
13. Pramipexole protects against H2O2-induced PC12 cell death.
Fujita Y; Izawa Y; Ali N; Kanematsu Y; Tsuchiya K; Hamano S; Tamaki T; Yoshizumi M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):257-66. PubMed ID: 16362428
[TBL] [Abstract][Full Text] [Related]
14. Dopamine agonists: the treatment for Parkinson's disease in the XXI century?
Lledó A
Parkinsonism Relat Disord; 2000 Nov; 7(1):51-58. PubMed ID: 11008196
[TBL] [Abstract][Full Text] [Related]
15. Dopamine agonist monotherapy in Parkinson's disease.
Clarke CE; Guttman M
Lancet; 2002 Nov; 360(9347):1767-9. PubMed ID: 12480442
[TBL] [Abstract][Full Text] [Related]
16. Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease.
Linazasoro G;
J Neurol; 2004 Mar; 251(3):335-9. PubMed ID: 15015015
[TBL] [Abstract][Full Text] [Related]
17. Minocycline protects dopaminergic neurons against long-term rotenone toxicity.
Radad K; Moldzio R; Rausch WD
Can J Neurol Sci; 2010 Jan; 37(1):81-5. PubMed ID: 20169778
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of pramipexole against tunicamycin-induced cell death in PC12 cells.
Nakayama H; Zhao J; Ei-Fakhrany A; Isosaki M; Satoh H; Kyotani Y; Yoshizumi M
Clin Exp Pharmacol Physiol; 2009 Dec; 36(12):1183-5. PubMed ID: 19515063
[TBL] [Abstract][Full Text] [Related]
19. Rapamycin protects dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture.
Radad K; Moldzio R; Rausch WD
Folia Neuropathol; 2015; 53(3):250-61. PubMed ID: 26443316
[TBL] [Abstract][Full Text] [Related]
20. The exceptional properties of 9-methyl-beta-carboline: stimulation, protection and regeneration of dopaminergic neurons coupled with anti-inflammatory effects.
Polanski W; Enzensperger C; Reichmann H; Gille G
J Neurochem; 2010 Jun; 113(6):1659-75. PubMed ID: 20374418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
